W. R. Eric Jamieson, MD, Guy J. Fradet, MD, James G

Slides:

Advertisements

Similar presentations

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Advertisements

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Twenty-Five Year Experience With the St

Clinical event rates with the On-X bileaflet mechanical heart valve: A multicenter experience with follow-up to 12 years John B. Chambers, MD, FRCP,

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation? Christos G. Mihos, DO, Orlando Santana,

Clinical experience with the carbomedics valve: Early results with a new bileaflet mechanical prosthesis J.Francisco Nistal, MD, Aquilino Hurlé, MD,

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study Vincent Chan,

Paravalvular regurgitation after conventional aortic and mitral valve replacement: A benchmark for alternative approaches Brett F. Duncan, MD, Patrick.

Challenging homografts as the holy grail for aortic valve endocarditis

Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD

Prospective randomized comparison of CarboMedics and St

Bigger valve size is not always better

Association between indices of prosthesis internal orifice size and operative mortality after isolated aortic valve replacement Charles R. Bridges, MD,

Advancing the science of myocardial recovery with mechanical circulatory support: A Working Group of the National, Heart, Lung, and Blood Institute Stavros.

A new approach: Ischemic mitral regurgitation guidelines by and for surgeons Patrick M. McCarthy, MD The Journal of Thoracic and Cardiovascular Surgery

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery Vincent Chan, MD, MPH, Thierry.

Early degeneration of the St Jude Medical Trifecta bioprosthetic aortic valve: A problem of the leaflets or of the stent? Giuseppe Santarpino, MD, Steffen.

Bicuspid aortic valve aortopathy: One size fits all?

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Michael A. Borger, MD, PhD, Patricia M

The variability of the mitral valve anatomy and terminology

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,

Quality of mitral valve surgery at the United States Department of Veterans Affairs Juan A. Crestanello, MD The Journal of Thoracic and Cardiovascular.

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

Aortic valve replacement with the Mitroflow pericardial bioprosthesis: Durability results up to 21 years Charles A. Yankah, MD, PhD, Miralem Pasic, MD,

Age alone should not preclude surgery: Contemporary outcomes after aortic valve replacement in nonagenarians Isaac George, MD, Halit Yerebakan, MD, Bindu.

Twenty-year experience with the St Jude Medical mechanical valve prosthesis John S Ikonomidis, MD, PhD, John M Kratz, MD, Arthur J Crumbley, MD, Martha.

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Fifteen years of experience with ATS mechanical heart valve prostheses

Torsten Doenst, MD, PhD, Markus Richter, MD

Robert W. Emery, MD, Christopher C. Krogh, Kit V. Arom, MD, PhD, Ann M

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Kevin Bridge, MD, MSPH, Robert Saeid Farivar, MD, PhD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Replicating the success of mitral valve repair in the aortic valve

The CarboMedics supra-annular Top Hat valve improves long-term left ventricular mass regression Victor X. Mosquera, MD, PhD, Alberto Bouzas-Mosquera,

Thirty-year experience with a bileaflet mechanical valve prosthesis

St Jude Medical Regent valve

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Effect of Prosthesis-Patient Mismatch on Long-Term Survival With Aortic Valve Replacement: Assessment to 15 Years W.R. Eric Jamieson, MD, Jian Ye, MD,

Sutureless valve implantation: Every detail counts

Biomaterials for heart valve replacement: Conjectures and refutations

Warfarin or aspirin after mitral valve repair: Why work harder?

Hans-Joachim Schäfers, MD

The harder one looks, the more one finds

Arnt E Fiane, MD, Odd R Geiran, MD, PhD, Jan L Svennevig, MD, PhD

Concomitant replacement of the ascending aorta is free—for some

First nights, the adrenal axis, and steroids

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

Effect of Prosthesis-Patient Mismatch on Long-Term Survival With Mitral Valve Replacement: Assessment to 15 Years W.R. Eric Jamieson, MD, Eva Germann,

The future of cardiac surgery training: A survival guide

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

Evaluating the best approach to treatment of aortic stenosis: The jury is still out Glen B. Taksler, PhD The Journal of Thoracic and Cardiovascular Surgery

Clinical event rates with the On-X bileaflet mechanical heart valve: A multicenter experience with follow-up to 12 years John B. Chambers, MD, FRCP,

Apples remain apples NO matter what

Francesco Nappi, MD, Cristiano Spadaccio, MD, PhD

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Presentation transcript:

Seven-year results with the St Jude Medical Silzone mechanical prosthesis W.R. Eric Jamieson, MD, Guy J. Fradet, MD, James G. Abel, MD, Michael T. Janusz, MD, Samuel V. Lichtenstein, MD, PhD, Joan S. MacNab, Elizabeth A. Stanford, BScN, Florence Chan The Journal of Thoracic and Cardiovascular Surgery Volume 137, Issue 5, Pages 1109-1115.e2 (May 2009) DOI: 10.1016/j.jtcvs.2008.07.070 Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 All-cause mortality overall and for aortic valve replacement (AVR), mitral valve replacement (MVR), and multiple replacements (MR). The Journal of Thoracic and Cardiovascular Surgery 2009 137, 1109-1115.e2DOI: (10.1016/j.jtcvs.2008.07.070) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Major paraprosthetic leak (reoperation and fatal) overall and for aortic valve replacement (AVR), mitral valve replacement (MVR), and multiple replacements (MR). The Journal of Thoracic and Cardiovascular Surgery 2009 137, 1109-1115.e2DOI: (10.1016/j.jtcvs.2008.07.070) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Valve-related reoperation overall and for aortic valve replacement (AVR), mitral valve replacement (MVR), and multiple replacements (MR). The Journal of Thoracic and Cardiovascular Surgery 2009 137, 1109-1115.e2DOI: (10.1016/j.jtcvs.2008.07.070) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Paraprosthetic leak reoperation overall and for aortic valve replacement (AVR), mitral valve replacement (MVR), and multiple replacements (MR). The Journal of Thoracic and Cardiovascular Surgery 2009 137, 1109-1115.e2DOI: (10.1016/j.jtcvs.2008.07.070) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Paraprosthetic leak reoperation mortality overall. The Journal of Thoracic and Cardiovascular Surgery 2009 137, 1109-1115.e2DOI: (10.1016/j.jtcvs.2008.07.070) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Overall thromboembolism, minor thromboembolism (TE), reversible ischemic neurologic deficits, major TE with/without thrombosis plus major systemic embolism (overall). The Journal of Thoracic and Cardiovascular Surgery 2009 137, 1109-1115.e2DOI: (10.1016/j.jtcvs.2008.07.070) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Combined reversible ischemic neurologic deficit (RIND) and major thromboembolism (major TE) with thrombosis plus major systemic embolism overall and for aortic valve replacement (AVR), mitral valve replacement (MVR), and multiple replacements (MR). The Journal of Thoracic and Cardiovascular Surgery 2009 137, 1109-1115.e2DOI: (10.1016/j.jtcvs.2008.07.070) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Combined reversible ischemic neurologic deficit (RIND) and major thromboembolism (major TE) without thrombosis plus major systemic embolism overall and for aortic valve replacement (AVR), mitral valve replacement (MVR), and multiple replacements (MR). The Journal of Thoracic and Cardiovascular Surgery 2009 137, 1109-1115.e2DOI: (10.1016/j.jtcvs.2008.07.070) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Thrombosis overall and for mitral valve replacement (MVR). The Journal of Thoracic and Cardiovascular Surgery 2009 137, 1109-1115.e2DOI: (10.1016/j.jtcvs.2008.07.070) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Antithrombotic hemorrhage overall and for aortic valve replacement (AVR), mitral valve replacement (MVR), and multiple replacements (MR). The Journal of Thoracic and Cardiovascular Surgery 2009 137, 1109-1115.e2DOI: (10.1016/j.jtcvs.2008.07.070) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Prosthetic valve endocarditis overall and for aortic valve replacement (AVR), mitral valve replacement (MVR), and multiple replacements (MR). The Journal of Thoracic and Cardiovascular Surgery 2009 137, 1109-1115.e2DOI: (10.1016/j.jtcvs.2008.07.070) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions